Pandemic and transformative technologies fuel growth in pharma outsourcing sector: CPHI North America panel
Transformative technologies and the opportunities afforded by the COVID-19 pandemic have spurred investment in the life sciences outsourcing sector, according to a panel of industry experts speaking at CPHI North America on Monday.
In the webinar, US Pharmaceutical Market Outlook 2021: CDMO Deal Making in a Pandemic and Beyond, James Gale, Managing Director at private equity firm, Signet Healthcare Partners, told the audience that despite an initial economic slowdown in 2020 due to pandemic-linked uncertainty, “as a lot of money was pushed into the economy by the fed, the capital markets have gone up dramatically creating a huge inflow of cash to the life sciences industry and supporting R&D activities.”
Gale said the breakthrough achievement of the COVID vaccines by Pfizer and Moderna has spawned an entirely new platform for vaccine development.
“Our belief is that there are exciting new technologies that are coming along that are transforming the practice of medicine, principally things like immunotherapy, cell and gene therapy, new vaccine forms that are increasingly creating new opportunities for treating patients,” he added. “These are the kind of technologies that have really engendered a lot of enthusiasm for growth and much of that is being outsourced.”
He said that during the last year, Signet has been involved in five life sciences transactions including an investment in CDMO Ascendia Pharmaceuticals, a recapitalisation of CDMO CoreRx, acquisitions of speciality devices company, GI Supply and pharma services company, Altasciences and the sale of viral vector-based CDMO, Vigene Biosciences.
Also on the panel, Robert Bloder, Chief Business Officer, Ascendia Pharmaceuticals described the Signet deal as “one that was in the gun sights of our founder CEO Jim Huang for several years as he had been bootstrapping the company for around nine years and really looking at one significant investment and building out his portfolio of technology platforms that allows us to work with virtually all of the dosage forms available today, which is important for new chemical entity and early stage work.”
He added that the investment is key for Ascendia to continue to grow with its partners “that we have built trust with from the very beginning in the nascency of their molecules and their investments and we wanted a route that was a strategic partner for us.”
“As we continue to expand in both our sterile and non-sterile facilities we see that serving us well in the short and intermediate terms,” he said.
Ramesh Subramanian, Chief Commercial Officer at CDMO Aragen Life Sciences (formerly GVK Bio) said that investment bank Goldman Sachs had recently taken an approximately one-third minority stake in the company after the exit of one private equity investor.
After a process lasting 12 months, which started with interest from around ten funds, Goldman Sachs was chosen from a shortlist of three blue chip funds.
“We thought Goldman was the best, based on the valuation based on their vision for where they wanted to go with the company,” Subramanian said. “The goal with Goldman is that they bring a lot of intellectual and financial capital to Aragen and we have very aggressive plans both in terms of adding capabilities and growing new geographies and with then as a partner it allows us to get there sooner.”
To register for our four-week hybrid event, CPHI North America and to watch the full webinar on demand, click here.
Related News
-
News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Women in Pharma: Minding the Gap at Pharmapack 2024
2024 marks the first year Pharmapack will host a Diversity track dedicated to bridging the gap within the pharmaceutical packaging and drug delivery sector. The track includes a panel discussion on 'Enabling Diversity in the Workplace,' focused... -
News Pharmapack Awards 2024 - Celebrating Packaging and Drug Delivery Innovation
The 2024 Pharmapack Innovation Awards ceremony celebrated the best in pharmaceutical packaging and drug delivery innovation at all levels. The awards were held on January 24, 2024 at the Paris Expo Porte de Versailles. -
News 2024 Pharma Industry Trends Outlook: Collaboration, Market Maturity, and Digital Futures
The annual CPHI Online 2024 Pharma Trends Outlook, in partnership with Arvato Systems, identifies 12 key industry trends shaping the life sciences industry in the coming year. -
News New Novo Nordisk AI hub for drug discovery to open in London, UK
Danish pharmaceutical giant Novo Nordisk will be opening an AI-based research facility in the heart of London to advance drug discovery operations. -
News BioNTech to begin mRNA vaccine manufacturing in Rwanda by 2025
German biotechnology company BioNTech has stated their intentions to begin production at their mRNA vaccine factory in Rwanda by 2025, which will mark the first foreign mRNA vaccine manufacturing site on the continent of Africa. -
News Women in Pharma: Looking back on 2023 and moving forward to 2024
In this monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News CPHI Barcelona 2023: Partnering for Success – Managing Outsourcing Relationships to Optimise Manufacturing Operations
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance